Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1999 Apr;229(4):493–497. doi: 10.1097/00000658-199904000-00007

Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial.

M Dahlberg 1, B Glimelius 1, L Påhlman 1
PMCID: PMC1191734  PMID: 10203081

Abstract

OBJECTIVE: The Swedish Rectal Cancer Trial (SRCT) demonstrated that a short-term regimen of high-dose preoperative radiotherapy (5 x 5 Gy) not only reduced the local recurrence rates but also improved the overall survival rate. This compelling evidence will have a significant impact on the primary treatment of rectal cancer. The authors' aim was to explore the representativeness of the study. SUMMARY BACKGROUND DATA: Until the SRCT was presented in 1997, no major trial had established that radiotherapy has a positive effect on the overall survival rate. METHODS: A review of all rectal cancer cases reported to the Swedish Cancer Registry during the same period that the SRCT accrued patients (1987 to 1990) was performed at 57 of 68 participating hospitals. At these 57 hospitals, there were 2366 patients with invasive rectal cancer, with 1664 of these patients fulfilling the criteria for inclusion in the SRCT. RESULTS: Fifty-two percent (866/1664) of eligible patients were included in the SRCT. The patients not included, of whom 8% (67/798) received adjuvant radiotherapy, had an overall 5-year survival rate of 48%, which was identical to the overall survival rate in the SRCT surgery-alone group (48%) but was inferior to the SRCT radiotherapy group (58%). The cancer-specific 5-year survival rates were 65% and 66% among the patients not included and the surgery-alone group, respectively. The local recurrence rates reached 27% in both groups. The results were still comparable when stratifying for curative surgery, tumor stage, and surgical procedure. CONCLUSIONS: The achieved inclusion level of 52% in a randomized multicenter trial is comparatively high. Because the population in the SRCT was representative, it was concluded that the study results are reliable.

Full text

PDF
493

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balslev I., Pedersen M., Teglbjaerg P. S., Hanberg-Soerensen F., Bone J., Jacobsen N. O., Overgaard J., Sell A., Bertelsen K., Hage E. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer. 1986 Jul 1;58(1):22–28. doi: 10.1002/1097-0142(19860701)58:1<22::aid-cncr2820580106>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  2. Buyse M., Zeleniuch-Jacquotte A., Chalmers T. C. Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA. 1988 Jun 24;259(24):3571–3578. [PubMed] [Google Scholar]
  3. Fisher B., Wolmark N., Rockette H., Redmond C., Deutsch M., Wickerham D. L., Fisher E. R., Caplan R., Jones J., Lerner H. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst. 1988 Mar 2;80(1):21–29. doi: 10.1093/jnci/80.1.21. [DOI] [PubMed] [Google Scholar]
  4. Glimelius B., Isacsson U., Jung B., Påhlman L. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment. Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):281–287. doi: 10.1016/s0360-3016(96)00510-x. [DOI] [PubMed] [Google Scholar]
  5. Goldberg P. A., Nicholls R. J., Porter N. H., Love S., Grimsey J. E. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer. 1994;30A(11):1602–1606. doi: 10.1016/0959-8049(94)00312-s. [DOI] [PubMed] [Google Scholar]
  6. Gérard A., Buyse M., Nordlinger B., Loygue J., Pène F., Kempf P., Bosset J. F., Gignoux M., Arnaud J. P., Desaive C. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg. 1988 Nov;208(5):606–614. doi: 10.1097/00000658-198811000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heald R. J., Karanjia N. D. Results of radical surgery for rectal cancer. World J Surg. 1992 Sep-Oct;16(5):848–857. doi: 10.1007/BF02066981. [DOI] [PubMed] [Google Scholar]
  8. Hojo K., Sawada T., Moriya Y. An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum. 1989 Feb;32(2):128–133. doi: 10.1007/BF02553825. [DOI] [PubMed] [Google Scholar]
  9. Horn A., Halvorsen J. F., Dahl O. Preoperative radiotherapy in operable rectal cancer. Dis Colon Rectum. 1990 Oct;33(10):823–828. doi: 10.1007/BF02051916. [DOI] [PubMed] [Google Scholar]
  10. Krook J. E., Moertel C. G., Gunderson L. L., Wieand H. S., Collins R. T., Beart R. W., Kubista T. P., Poon M. A., Meyers W. C., Mailliard J. A. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991 Mar 14;324(11):709–715. doi: 10.1056/NEJM199103143241101. [DOI] [PubMed] [Google Scholar]
  11. MacFarlane J. K., Ryall R. D., Heald R. J. Mesorectal excision for rectal cancer. Lancet. 1993 Feb 20;341(8843):457–460. doi: 10.1016/0140-6736(93)90207-w. [DOI] [PubMed] [Google Scholar]
  12. Marsh P. J., James R. D., Schofield P. F. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial. Dis Colon Rectum. 1994 Dec;37(12):1205–1214. doi: 10.1007/BF02257783. [DOI] [PubMed] [Google Scholar]
  13. Mattsson B., Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23(5):305–313. doi: 10.3109/02841868409136026. [DOI] [PubMed] [Google Scholar]
  14. Påhlman L., Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg. 1990 Feb;211(2):187–195. doi: 10.1097/00000658-199002000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Påhlman L., Glimelius B. The value of adjuvant radio(chemo)therapy for rectal cancer. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1347–1350. doi: 10.1016/0959-8049(95)91268-h. [DOI] [PubMed] [Google Scholar]
  16. Treurniet-Donker A. D., van Putten W. L., Wereldsma J. C., Bruggink E. D., Hoogenraad W. J., Roukema J. A., Snijders-Keilholz A., Meijer W. S., Meerwaldt J. H., Wijnmaalen A. J. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer. 1991 Apr 15;67(8):2042–2048. doi: 10.1002/1097-0142(19910415)67:8<2042::aid-cncr2820670806>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  17. Wilcox B. R., Stritter F. T. Curriculum change for graduate education in thoracic surgery. Ann Thorac Surg. 1993 May;55(5):1332–1336. doi: 10.1016/0003-4975(93)90084-u. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES